Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Gland Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:543245NSE Symbol: GLANDP/E(TTM):25.24
ISIN Demat:INE068V01023Div & Yield %:1.02EPS(TTM):70.19
Book Value(Rs):610.0166926Market Cap ( Cr.):29191.54Face Value(Rs):1
    Change Company 
Date Headline
19-Nov-25 Volumes soar at Jaiprakash Power Ventures Ltd counter
07-Nov-25 Gland Pharma Ltd - Gland Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
03-Nov-25 Gland Pharma consolidated net profit rises 12.32% in the September 2025 quarter
03-Nov-25 Gland Pharma Ltd - Gland Pharma Limited - Investor Presentation
03-Nov-25 Gland Pharma Ltd - Gland Pharma Limited - Press Release
03-Nov-25 Gland Pharma Ltd - Gland Pharma Limited - Outcome of Board Meeting
31-Oct-25 Gland Pharma Ltd - Gland Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
18-Oct-25 Gland Pharma schedules board meeting
17-Oct-25 Gland Pharma Ltd - Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter And Half Year..
17-Oct-25 Gland Pharma Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
<< < 1 2 3 4   > >>